September 15, 2010

The common shares of Merus Labs International Inc. have been approved for listing on CNSX.  The Company has 13,732,716 shares outstanding with a public float of approximately 2.05 million shares.

Merus Labs' business objective is to develop a distribution network throughout North America for its licensed specialty pharmaceutical products and to market its products in North America through direct sales and a network of agents. The Company will seek to expand its revenues by (i) acquiring or in-licensing additional legacy products, and (ii) acquiring the rights to revenue streams and royalties generated primarily by legacy products owned by other pharmaceutical companies.

Merus Labs is considered a "thin float issuer" under CNSX Policy 2. 

Listing and disclosure documents for Merus Labs International Inc. will be available in the CNSX Listings Disclosure Hall

Trading Date: Thursday, September 16, 2010
Symbol: MR
CUSIP: 590475 10 9
ISIN: CA 590475 10 9 9

Applications are being accepted for Market Makers for "MR". If you have any questions or require further information please contact Radhika at (416) 572-2000 X 2435 or E-mail: radhika.ramkarran@cnsx.ca